ABVC BioPharma, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-3.0M | $-3.1M | $93.2K | $4.7M |
| Jun 2022 | $-3.4M | $-3.5M | $22.0K | $225.7K |
| Sep 2022 | $-513.7K | $-518.1K | $4.4K | $225.7K |
| Dec 2022 | $-461.1K | $-461.2K | $89 | $1.9M |
| Mar 2023 | $-1.5M | $-1.5M | — | $366.5K |
| Jun 2023 | $-899.8K | $-899.8K | — | $225.7K |
| Sep 2023 | $-1.4M | $-1.4M | — | $817.7K |
| Dec 2023 | $-430.5K | $-430.5K | — | $-1.2M |
| Mar 2024 | $-955.8K | $-955.8K | — | $2.0M |
| Jun 2024 | $-211.4K | $-211.4K | — | $282.9K |
| Sep 2024 | $60.2K | $60.2K | — | $95.9K |
| Dec 2024 | $-702.1K | $-702.1K | — | $363.1K |
| Mar 2025 | $-539.8K | $-539.8K | — | $48.8K |
| Jun 2025 | $-894.2K | $-894.2K | — | $1.6M |
| Sep 2025 | $-964.7K | $-964.7K | — | $1.1M |
| Dec 2025 | $-587.6K | $-587.6K | — | $1.4M |
| Mar 2026 | $-894.2K | $-894.2K | — | $787.4K |
| Jun 2026 | $-244.4K | $-244.4K | — | $253.0K |